Date Filed | Type | Description |
10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2023 |
4
| Mahmood Tahir Ph.D. (Director) has filed a Form 4 on Applied Molecular Transport Inc.
Txns:
| Sold 1,992 shares
@ $0.2413, valued at
$480.7 Sold 2,245 shares
@ $0.2075, valued at
$465.8 |
|
10/04/2023 |
4
| Hants Brandon (CFO) has filed a Form 4 on Applied Molecular Transport Inc.
Txns:
| Sold 1,643 shares
@ $0.2412, valued at
$396.3 Sold 560 shares
@ $0.24, valued at
$134.4 Sold 718 shares
@ $0.2075, valued at
$149 |
|
10/04/2023 |
4
| Cross Shawn (CEO & Chair of the Board) has filed a Form 4 on Applied Molecular Transport Inc.
Txns:
| Sold 3,293 shares
@ $0.2412, valued at
$794.3 Sold 536 shares
@ $0.2404, valued at
$128.9 Sold 477 shares
@ $0.2402, valued at
$114.6 Sold 1,253 shares
@ $0.2075, valued at
$260 |
|
10/02/2023 |
4
| Hants Brandon (CFO) has filed a Form 4 on Applied Molecular Transport Inc.
Txns:
| Granted 491,111 shares
@ $0 Sold 107,540 shares
@ $0.1585, valued at
$17k
|
|
10/02/2023 |
4
| Cross Shawn (CEO & Chair of the Board) has filed a Form 4 on Applied Molecular Transport Inc.
Txns:
| Granted 886,111 shares
@ $0 Sold 193,960 shares
@ $0.1585, valued at
$30.7k
|
|
09/27/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
09/27/2023 |
8-K
| Quarterly results |
08/14/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/14/2023 |
8-K
| Quarterly results |
07/24/2023 |
8-K
| Quarterly results |
06/15/2023 |
4
| VanDevender Aaron (Director) has filed a Form 4 on Applied Molecular Transport Inc.
Txns:
| Granted 20,000 options to buy
@ $0.34, valued at
$6.8k
|
|
06/15/2023 |
4
| Smither John W (Director) has filed a Form 4 on Applied Molecular Transport Inc.
Txns:
| Granted 20,000 options to buy
@ $0.34, valued at
$6.8k
|
|
06/15/2023 |
4
| Schachner Holly Caren (Director) has filed a Form 4 on Applied Molecular Transport Inc.
Txns:
| Granted 20,000 options to buy
@ $0.34, valued at
$6.8k
|
|
06/15/2023 |
4
| Mahmood Tahir Ph.D. (Director) has filed a Form 4 on Applied Molecular Transport Inc.
Txns:
| Granted 20,000 options to buy
@ $0.34, valued at
$6.8k
|
|
06/15/2023 |
4
| Banard Charlene A. (Director) has filed a Form 4 on Applied Molecular Transport Inc.
Txns:
| Granted 20,000 options to buy
@ $0.34, valued at
$6.8k
|
|
06/08/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
06/08/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/11/2023 |
8-K
| Quarterly results |
05/04/2023 |
8-K
| Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balan... |
04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/27/2023 |
8-K
| Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm... |
03/09/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
03/09/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/09/2023 |
8-K
| Quarterly results |
02/09/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
02/09/2023 |
SC 13G/A
| Mahmood Tahir Ph.D. reports a 9.7% stake in Applied Molecular Transport, Inc. |
02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
12/22/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|